Further support to the possible role of the NLRP3 inflammasome in PD is based on the knowledge that dopamine neurons negatively regulate NLRP3 by the dopamine D1 receptor (DRD1)-cyclic adenosine monophosphate (cAMP) signaling pathway. This evidence concerns the gene NLRP3 and Parkinson disease.